Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 69Rectal Neoplasms 10Triple Negative Breast Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Lung Neoplasms 6Carcinoma, Intraductal, Noninfiltrating 6Adenocarcinoma of Lung 6Breast Carcinoma In Situ 4Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Solitary Pulmonary Nodule 1Social Isolation 1Recurrence 1Piebaldism 1Patient Satisfaction 1Pain, Postoperative 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Colorectal Neoplasms 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1

Interventions

rocakinogene sifuplasmid 1Mastectomy, Segmental 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
BRCA1/2 Mutation × Mastectomy, Segmental × Clear all
NCT06429644 2024-05-28

Long-term Oncologic Outcome of Breast-conserving Surgery in Breast Cancer Patients With BRCA1/2 Mutations

Hanyang University Seoul Hospital

Completed
4,010 enrolled
Breast

BRCA1/2 Mutation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡